3 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia Fluvoxamine, Placebo - COVID-19, Olfactory Disorder | Phase 2 | Withdrawn | Washington University School of Medicine | 2021-12-14 | 2022-03-11 | |
| Coronavirus Smell Therapy for Anosmia Recovery Budesonide, High-Concentration Essential Oil, Placebo - Anosmia | Phase 2 | Withdrawn | Washington University School of Medicine | 2021-06-01 | 2021-03-02 | |
| Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery Budesonide Respules - Olfaction Disorders, Sinusitis | Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2013-03-01 | 2016-04-06 |
Anosmia (1) · COVID-19 (1) · Paranasal Sinus Diseases (1) · Sinusitis (1)
Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1)
Budesonide (2) · Fluvoxamine (1)
Washington University School of Medicine (2) · University of North Carolina, Chapel Hill (1)
United States (3)
Adam M Zanation, MD (1) · Jay F Piccirillo, MD (1)